Molecular Imaging Seminar Dec 2012

Dr. Rao Papineni : Imaging in vivo ROS Activity in Inflammation and Cancer

3rd International Cancer Research Symposium

2012
Defining & Translating Science for Disease Prevention and Therapy SWISSOTEL
Plot No. 11/5, Action Area 2-D, New Town, Rajarhat, Kolkata-700157, West Bengal, India

Venue:

19 - 21 December, 2012
Topics to be addressed :

(a) Application of Emerging Technologies in Cancer Research (b) Genetic and Epigenetic Mechanisms in the Pathobiology of Cancer (c) Novel Therapies (Immuno-and Stem Cell-based Therapies) (d) Complementary and Alternative Approaches for Cancer Prevention and Therapy Organizing Committee (USA) Sushanta K. Banerjee (Chair) C.V.Rao ,(Co-Chair) Rajesh Agarwal , (Co-Chair) Shivendra Singh , (Co-Chair) Organizing Committee (India) Dhrubajyoti Chattopadhyay (Chair) Gopal Kundu (Co Chair) Bhudev C Das (Co-Chair) Secretaries Organizing Committee Gaurisankar Sa (Secretary) Urmi Chatterji (Secretary) Treasurer Alok Kumar Sil

Nitai Bhattacharyya Tanya Das Chinmay Panda Deepak Mishra

Sharmila Sengupta Mrinal Ghosh Diptendra Sarkar

Contact
USA INDIA

Joi Wickliffe jwfckliffe@vamccancerresearchunit.org Tel: 816-861-4700x57922

Atanu Roy Chowdhury atanu.roychowdhury@ymail.com Tel: 2335-0067

3rd International Cancer Research Symposium 2012 Defining & Translating Science for Disease Prevention and Therapy
19-21 December, 2012

Plot No. 11/5, Action Area 2-D, New Town, Rajarhat Kolkata, West Bengal 700157, India

The Registration Fee (along with the Registration Form) has to be paid as follows: Payment through Demand Draft, multicity account payee cheque or Money Transfer / National Electronic Fund Transfer (NEFT/RTGS) only. Demand draft or multicity account payee cheque should be drawn in favour of 3rd ICRS 2012 payable at Kolkata (Registration will be confirmed after realization of cheques). Money transfer/NEFT/RTGS (Inter-Bank Transfer): State Bank of India, Calcutta University Branch, IFSC Code SBIN0007766, A/C No. 32470598175. Money transfer can also be done through Internet Banking. Wire transfer for Foreign Remittance through SWIFT Code SBININBB106 Please write your name and address on the back of the Bank Draft without fail and also enclose three stamp size photographs

Last Date of Registration: 15 October, 2012

Completed registration forms and abstracts (if applicable) should be mailed to:

3rdicrs.2012@gmail.com

(presenting authors name underlined), place of work, contact telephone number and email address. The abstract should have an Introduction, Material and Methods, Results and a Conclusion Section. The authors should indicate in the registration form whether they prefer to make a Poster or Oral presentation.

ABSTRACTS should be 2000 characters or less with space and have a title, authors names

Director, Centre for Research in Nanoscience and Nanotechnology JD-2, Sector-III, Salt Lake, Kolkata-700 098, West Bengal Telephone : +91 +033-2335 0067 / Fax : +91 +033-2257 1470 E-mail: 3rdicrs.2012@gmail.com Website : http://www.3rdicrs2012.org

Prof. D. J. Chattopadhyay

Address for correspondence:

3rd International Cancer Research Symposium 2012 Defining & Translating Science for Disease Prevention and Therapy
19-21 December, 2012
Plot No. 11/5, Action Area 2-D, New Town, Rajarhat, Kolkata, West Bengal 700157, India

Prefix Prof./ Dr./ Mr./ Ms. First name, Surname Gender Department Institution Address City PIN FAX Nationality
Registration 15 October, 2012 Spot registration

Faculty/ Clinician

PDF

Scholar

Male

Female

State Tel # Email

Indian NRI
Students and PDFs Rs. 1,500 Rs. 2,500

Country Cell #

Foreign
Faculty and Clinicians Rs. 3,000 Rs. 5,000

Category of Participation

Invited Speaker

Young Scientist

Delegate

General

Submitting abstract? Food preference

YES VEG

NO

If yes, ORAL NON-VEG

POSTER

cv

TITLE SPEAKER
1. Addanki Pratap Kumar , Ph.D (USA) Translation of complementary and alternate
*(TBA-to

be announced, presenter has yet to provide a title)

medicinal modalities from bench to bedside.

2. Adhip N Majumdar, Ph.D. (USA) Cancer Stem Cells: Implications for Colorectal Carcinogenesis and Development of Therapeutic Strategies

3.

Ajay Rana, Ph.D. (USA) Mixed Lineage Kinases: Novel Therapeutic Targets of Proliferative and Degenerative Diseases

4. Alakananda Basu, Ph.D. (USA) Targeting AGC Kinases in Breast Cancer

5. Alo Nag, Ph.D. (IND) Combating Cancer Through Discovery of Novel Molecular Targets.

6. Alok De, Ph.D. (USA) Prevents Ovarian Carcinogenesis by Amla

7.

Amitava Chatterjee, Ph.D. (IND) MMP-2 a potential marker of breast cancer

8. Andrew Leask, Ph.D. (CAN) Managing the microenvironment: matricellular adhesive proteins as signaling modulators in skin

9.

Anuradha Sehrawat, PhD (USA)

Inhibition Transition Cruciferous by

of

Epithelial-Mesenchymal Benzyl Isothiocyanate, A Cancer

Vegetable-Derived

Chemopreventive Agent

10. Arun Kumar Sharma, Ph.D. (USA)

Developing therapeutics

selenium

based

cancer

11. Bandana Chatterjee, Ph.D. (USA) Targeting Intra tumor Androgen Signaling in Prostate Cancer via Enzymatic Sulfation: A Nuclear Receptor-directed Novel Treatment Approach 12. Barbara Dunn, Ph.D. (USA) Update of Clinical Trials in Breast Cancer

13. Bhudev Das, Ph.D. (IND)

TBA

14. Bimal Ray, Ph.D. (USA) Targeting a Novel Epigenetic Regulatory

Mechanism for Breast Cancer

15. C.V. Rao, Ph.D. (USA) Transcriptomic Approaches: Prevention and

Treatment of GI Cancers

16. Chandi Charan Mandal, Ph.D. (USA) A Cholesterol-lowering Drug Targets

Osteoclastogenic Factors to Prevent Osteolytic Bone Metastasis of Breast Cancer 17. Chandrani Sarkar, Ph.D. (USA) TBA

18. Charles Giardina, Ph.D. (USA) New experimental approaches for identifying novel colon cancer chemopreventive agents

19. Chendil Damodaran, Ph.D (USA)

Modulating AKT induced Epithelial Mesenchymal Transition for Prevention and Treatment of Colon Cancer

20. Chimnay Kumar Panda, Ph.D. (IND)

Molecular analysis of cellular pathways associated with the development of uterine cervical carcinoma

21. Dipak Banerjee, Ph.D. (USA-PR) Tunicamycin Inhibits Angiogenesis and Prevents Breast Cancer Progression

22. Dipak Sarkar, Ph.D. (USA) Current Research Work on Role of beta-endorphin in Cancer Prevention

23. Dulal Panda, Ph.D. (IND)

TBA

24. Ellora Sen, Ph.D. (IND) Tumor necrosis factor (TNFa) regulates radioresistance in glioblastoma

25. Ernest Hawk, MD (USA) Clinical Agent Development for CRC Prevention.

26. Gopal Chakrabarti, Ph.D. (IND) Targeted Drug Development: Synthetic thiadiazole NMK-TD-100, a novel microtubule modulating agent, induces apoptosis and autophagy in cancer cells. 27. Gopal Kundu, Ph.D. (IND) Osteopontin and Related Proteins: Role in Inflammation, Angiogenesis Cancer and Pathological

28. Goutam (USA)

GhoshChoudhury,

Ph.D. MicroRNAs in renal cancer and tumor suppressor protein PTEN".

29. Hari Koul, Ph.D. (USA) Sam Pointed Domain Transcription Factor: A New Tumor Metastasis Suppressor

30. Jamboor Vishwanatha, Ph.D. (USA) Reciprocal Regulation of Her-2 and Annexin A2 in Breast Cancer

31. James W. Freeman, Ph.D. (USA) Molecular Targets for Therapy of the in

Chemoresistant/Stem Pancreatic Cancer.

Cell

Phenotype

32. Joan Cunningham, Ph.D. (USA) Using massage therapy to treat chemotherapyinduced peripheral neuropathy

33. Kapil Mehta, Ph.D. (USA) Targeting Inflammation to Prevent Cancer

Progression

34. Kattesh V. Katti, Ph.D. (USA) How can we achieve tumor staurticity of fast growing and inoperable metastatic Cancers

35. Lester F. Lau, Ph.D. (USA) The Matricellular Protein CCN1 in Inflammatory Diseases and Cancer

36. Lucio Miele, MD, Ph.D. (USA) Development of Notch inhibitors in breast cancer: targeting stem cell pathways

37. Mahitosh Mandal (IND) The potential of celecoxib-loaded hydroxyapatitechitosan nanocomposite for the treatment of colon cancer

38. Mausumi Bharadwaj, Ph.D. (IND) The genetic and epigenetic regulation of

carcinogenesis in Human Papilloma Virus assoc. epithelial cancer

39. Michael J. Wargovich, (USA) Epigenetic Mechanisms in the Chemoprevention of Colon Cancer by Tea Polyphenol, EGCG

40. Ming You, MD (USA)

TBA

41. Mohamed Saleem (Bhat), Ph.D (USA) Strategies to Tame the Activities of Androgen Receptor for Treating Androgen-independent Prostate Cancer

42. Mrinal Kanti Ghosh, Ph.D. (IND)

Area on basic mechanistic understanding of cancer cell signaling and crosstalk

43. Nandini Ghsh-Choudhury ,Ph.D. (USA) Omega 3 Fatty Acids Differentially Target

OncomiRs and Tumor Suppressor micro-RNAs to Prevent Breast Cancer Metastasis 44. Neil Bhowmick, PhD (USA) Targeted therapeutics require tumor microenvironment considerations

45. Nitai P. Bhattacharyya, Ph.D. (IND)

TBA

46. Ossama Tawfik, MD, Ph.D. (USA) What Does a Pap Smear Have to do with Telepathology? TelePAPology the New Kid on the Block!!

47. Pamela Munster, MD, Ph.D. (USA) Reversal of hormone therapy resistance by epigenetic modulation

48. Partha P. Majumdar, Ph.D. (IND) GENOMIC ORAL ALTERATIONS IN GINGIVO-BUCCAL BY MASSIVELY-

CANCER,

IDENTIFIED

PARALLEL DNA SEQUENCING

49. Peeyush Lala, MD, Ph.D (CAN) COX-2 and COX-2 induced miRNAs in breast cancer progression: sustenace of Stem-like cells

50. Peter Van Velduizen, MD (USA) Prostate Cancer: New Paradigms and

Approaches to Active Surveillance

51. Prasanta

Banerji

(IND)

and

Pratip The Banerji Protocols: The Regression of Malignant Tumors by a Non-Toxic and Non-Invasive Oral

Banerji ,MD (IND)

Medical Approach

52. Priyabrata Mukherjee , Ph.D. (USA) Nanomedicine: Opportunities and Challenges in Cancer Therapy

53. Raj K. Tiwari, Ph.D. (USA) Cancer Vaccines : Evolving Paradigms

54. Rajagopal Ramesh, Ph.D. (USA) TUSC2/FUS1-gene-based nanotherapy for lung cancer: From Mice to Humans

55. Rajendra G. Mehta, Ph.D (USA) Deguelin as a possible chemopreventive and therapeutic agent for breast cancer

56. Rajesh Agarwal, Ph.D. (USA) Epigenetic Mechanisms Contributing to the Anticancer Efficacy of Silibinin in Non-small Cell Lung Cancer

57. Rajkumar (USA)

Lakshmanaswamy,

Ph.D.

Pregnancy, Hormones, and Breast Cancer

58. Rao Papineni, Ph.D. (USA) Imaging in vivo ROS Activity in Inflammation and Cancer A non invasive approach

59. Ratna Chakrabarti , Ph.D. (USA) Actin cytosketon modulatory protein LIM kinase 1 and functional regulation of MT1-MMP: Implication in invasion of prostate cancer cells 60. Ratna Ray, Ph.D. (USA) Prostate Cancer: Potential for Prevention and Therapy

61. Richard Eckert, Ph.D.(USA) Polycomb Genes, chemoprevention and skin cancer response to cell stress

62. Rita Mulherker, Ph.D. (IND) Gene Therapy for Head and Neck cancer: From lab to Clinics

63. Robert Sclafani, Ph.D. (USA) Molecular Mechanism of Cancer Chemoprevention by Resveratrol.

64. Rod Dashwood (USA) Epigenetics, diet, and cancer: Convergence of histone marks, DNA methylation, and miRNA profiling in chemoprevention studies

65. Roy Jensen, MD (USA) Overcoming BRCA1 Mediated Chemotherapeutic and Radiation Resistance in Cancer

66. Samarendra N. Banerjee, Ph.D (IND)

Anti-angiogenic therapy on in vivo tumor bearing mouse model System

67. Sanjay Gupta, Ph.D. (USA) PLANT FLAVONOIDS AS EPIGENETIC MODULATORS IN CANCER: IMPLICATIONS IN CANCER CHEMOPREVENTION

68. Sankar Mitra, Ph.D (USA)

TBA

69. Sen Pathak, Ph.D. (USA)

Are telomeres involved in Cancer causation, drug discovery and prevention?

70. Shailesh Singh (USA)

TBA

71. Sharmila Sengupta, Ph.D (IND)

TBA

72. Sheo Mohan Singh, Ph.D. (IND)

Role of myeloid transcription factors in the pathogenesis of leukemic cancers

73. Shivendra Singh , Ph.D. (USA)

TBA

74. Shrikant Anant , Ph.D. (USA)

TBA

75. Snigdha Banerjee, Ph.D. (USA) The role of PDGF-B-NRP-1 signaling in

mesenchymal to pericytes transition during tumor angiogenesis

76. Soumen Paul, Ph.D. (USA) Protein Kinase C Signaling: from Embryonic Stem Cell to Cancer

77. Subash Basu ,PhD, D.Sc (USA) Probable New Therapeutic Drugs for Breast and Colon Cancers

78. Subhamoy Dasgupta, PhD (USA) Steroid Receptor Coactivator in Oncogenic Reprogramming of Cancer Cell Metabolism.

79. Sujit Basu, MD, Ph.D. (USA)

TBA

80. Suman Kambhampati, MD (USA) A Second Generation 2-Methoxyestradiol Prodrug is Effective against Barretts Adenocarcinoma in a Mouse Xenograft Model 81. Sushanta K. Banerjee, Ph.D (USA) Aspirin in breast carcinogenesis: A friend or foe

82. Tanya Das, Ph.D (IND) Targeting cancer stem cells: An approach towards next generation cancer therapy

83. Tapan Chaudhuri, MD (USA) Introduction to the science of acupuncture and its application in the realm of Cancer

84. Tapas Kundu, Ph.D (IND) Epigenetic Modifications as Targets of Cancer Therapeutics: Implications in Oral Cancer.

85. Thangarajan Rajkumar, Ph.D. (IND) Targeting EWS-FLT1 fusion protein

86. Theresa Pacheco, Ph.D (USA)

TBA

87. Tony Kong, MD (USA) Cancer Prevention by Dietary Phytochemicals: from Nrf2-mediated Anti-Oxidative Stress, Epigenetics to in vivo Cancer Models

88. Uddhav (USA)

Kelavkar,

PhD Dietary polyunsaturated fatty acids, cancer and chemoprevention

89. Urmi Chatterji, Ph.D (IND) Elucidating the molecular signaling adapted by artemisinin in cervical cancer cells

90. Virginia Savin, MD(USA)

Evaluating

renal

function

in

patients

undergoing chemotherapy

91. Xianglin Shi , MD, Ph.D (USA)

Plant-derived antioxidants and disease prevention

92. Xiaolin Zi , PhD (USA) Epigenetic chemoprevention of tobacco-related urinary bladder carcinogenesis by Kawain

93. Yogesh C Awasthi, PhD (USA)

TBA